Abstract:Lipid nanoparticles have attracted significant interests in the last two decades, and have achieved tremendous clinical success since the first clinical approval of Doxil in 1995. At the same time, lipid nanoparticles have also demonstrated enormous potential in delivering nucleic acid drugs as evidenced by the approval of two RNA therapies and mRNA COVID‐19 vaccines. In this review, an overview on different classes of lipid nanoparticles, including liposomes, solid lipid nanoparticles, and nanostructured lipid carriers, is first provided, followed by the introduction of their preparation methods. Then the characterizations of lipid nanoparticles are briefly reviewed and their applications in encapsulating and delivering hydrophobic drugs, hydrophilic drugs, and RNAs are highlighted. Finally, various applications of lipid nanoparticles for overcoming different delivery challenges, including crossing the blood–brain barrier, targeted delivery, and various routes of administration, are summarized. Lipid nanoparticles as drug delivery systems offer many attractive benefits such as great biocompatibility, ease of preparation, feasibility of scale‐up, nontoxicity, and targeted delivery, while current challenges in drug delivery warrant future studies about structure–function correlations, large‐scale production, and targeted delivery to realize the full potential of lipid nanoparticles for wider clinical and pharmaceutical applications in future. This article reviews the classification of different lipid nanoparticles, and their preparation and characterization. Their applications in encapsulating and delivering hydrophobic drugs, hydrophilic drugs, and RNAs for different diseases and how lipid nanoparticles enable nanomedicine to address the challenges of blood–brain barrier, targeted delivery, and various routes of administration are also discussed .

Virus-like particle-based nanocarriers as an emerging platform for drug delivery

Plant-Derived Vesicle-Like Nanoparticles: Clinical Application Exploration and Challenges

Overcoming Biological Barriers by Virus-Like Drug Particles for Drug Delivery.

Viral Nanoparticles‐Mediated Delivery of Therapeutic Cargo

Virus-Like Particle Engineering: From Rational Design to Versatile Applications

Nanovesicles as Potential Carriers for Delivery of Antiviral Drugs: A Comprehensive Review.

Plant-Derived Vesicle-like Nanoparticles: The Next-Generation Drug Delivery Nanoplatforms

A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems

Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery

Tailored Viral-Like Particles as Drivers of Medical Breakthroughs

Phage-based delivery systems: engineering, applications, and challenges in nanomedicines

[Recent Advances in Liposomes and Nanoparticles As Drug Carriers for Drug Delivery].

Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications

Genetically Engineered Viral Vectors and Organic‐based Non‐viral Nanocarriers for Drug Delivery Applications

Nanoparticles exhibiting virus-mimic surface topology for enhanced oral delivery

Camouflaged Virus-Like-Nanocarrier with a Transformable Rough Surface for Boosting Drug Delivery

Lipid Nanoparticles for Drug Delivery

Microfluidic Nanoparticles for Drug Delivery

Application of Non-Viral Vectors in Drug Delivery and Gene Therapy

Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy

Plant-derived nanoparticles and plant virus nanoparticles: Bioactivity, health management, and delivery potential